Glioblastoma
Glioblastoma is a fast-growing and aggressive type of brain cancer that arises from glial cells, often leading to severe neurological symptoms and a challenging prognosis.
Glioblastoma: [177Lu]Lu-DOTA-TATE Treatment Study
We are exploring a new drug for patients with newly diagnosed glioblastoma alongside standard care, and for those with recurrent glioblastoma as a single treatment. The goal is to find the best dose for effective treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Pierre Wertheimer
#1000:Service de neuro-oncologie
Bron, France
Assistance Publique Hopitaux De Marseille
#1001:Service Medecine Nucleaire
Marseille, France
Instituto Portugues De Oncologia Do Porto Francisco Gentil E.P.E.
#2000:Serviço Oncologia Médica
Paranhos, Portugal
Sponsor: Novartis Pharma AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.